A股異動丨美年健康逼近漲停 控股股東向阿里巴巴等轉讓公司16.16%的股份
格隆匯10月28日丨美年健康(002044.SZ)逼近漲停,報14.95元,成交5.3億元,總市值559.5億元。美年健康(002044.SZ)10月27日晚間公告稱,控股股東天億資產、股東天億控股、上海美馨分別與阿里網絡、杭州信投、上海麒鈞簽訂《股份轉讓協議》,向阿里網絡、杭州信投和上海麒鈞合計轉讓604,884,840股(佔公司總股本16.16%)。受讓價格為12.01元/股,較週五收盤折價12%。中金公司發佈研報稱,考慮阿里戰略入股後對美年健康的積極影響,上調公司目標價6.3%至17元。該公司分析師張璡等在最新的研究報告中指出,美年健康向阿里等轉讓股權後,預計公司近年來的個人體檢轉型戰略,有望藉助阿里系的流量入口得以突破。個檢業務的推廣有利於提升客單價,同時也較大幅度增強客户粘性。阿里戰略入股也有助於提升公司數字化、智能化發展水平和提升整體管理與服務體系,完善公司創新性技術平台的搭建。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.